Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine sarcoma.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation / Q000187:drug effects*; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D000951:Antigens, Neoplasm; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003864:Depression, Chemical; D007110:Immunity, Active; D007274:Injections, Intraperitoneal; D008297:Male; D008748:Methylcholanthrene; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000188:drug therapy*; D013997:Time Factors; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D008748:Methylcholanthrene; D003520:Cyclophosphamide